Methods for treating HCV
US9452194B2 · kind B2 · utility
0Cited by
56References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2014 |
| Grant date | Sep 27, 2016 |
| Priority date | — |
| Expiry date | Oct 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.